Cancer hormone therapy is a treatment approach that slows or stops the growth of hormone-sensitive cancers by blocking or reducing the body’s natural hormone production. The Middle East Cancer Hormone Therapy Market share is expected to reach US$ 534.8 million by 2031 from US$ 298.7 million in 2024. The market is estimated to record a CAGR of 8.7% from 2025 to 2031. The...